Publication:
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic

dc.contributor.authorMelidou, Angeliki
dc.contributor.authorPereyaslov, Dmitriy
dc.contributor.authorHungnes, Olav
dc.contributor.authorProsenc, Katarina
dc.contributor.authorAlm, Erik
dc.contributor.authorAdlhoch, Cornelia
dc.contributor.authorFielding, James
dc.contributor.authorSneiderman, Miriam
dc.contributor.authorMartinuka, Oksana
dc.contributor.authorCelentano, Lucia Pastore
dc.contributor.authorPebody, Richard
dc.contributor.authorWHO European Region
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorCasas Flecha, Inmaculada
dc.contributor.authorEuropean Influenza Surveillance Network (EISN)
dc.date.accessioned2022-09-02T10:08:44Z
dc.date.available2022-09-02T10:08:44Z
dc.date.issued2020-11
dc.description.abstractThe COVID-19 pandemic negatively impacted the 2019/20 WHO European Region influenza surveillance. Compared with previous 4-year averages, antigenic and genetic characterisations decreased by 17% (3,140 vs 2,601) and 24% (4,474 vs 3,403). Of subtyped influenza A viruses, 56% (26,477/47,357) were A(H1)pdm09, 44% (20,880/47,357) A(H3). Of characterised B viruses, 98% (4,585/4,679) were B/Victoria. Considerable numbers of viruses antigenically differed from northern hemisphere vaccine components. In 2020/21, maintaining influenza virological surveillance, while supporting SARS-CoV-2 surveillance is crucial.es_ES
dc.description.peerreviewedes_ES
dc.format.number46es_ES
dc.format.page2001822es_ES
dc.format.volume25es_ES
dc.identifier.citationEuro Surveill. 2020 Nov;25(46):2001822.es_ES
dc.identifier.doi10.2807/1560-7917.ES.2020.25.46.2001822es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro Surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID33213683es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14935
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2020.25.46.2001822es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectEuropees_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectInfluenza viruses_ES
dc.subjectPandemices_ES
dc.subjectSurveillancees_ES
dc.subjectVirus characterizationes_ES
dc.subject.meshEpidemiological Monitoringes_ES
dc.subject.meshAntigens, Virales_ES
dc.subject.meshBetacoronaviruses_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshCoronavirus Infectionses_ES
dc.subject.meshDisease Notificationes_ES
dc.subject.meshHumanses_ES
dc.subject.meshInfluenza A Virus, H1N1 Subtypees_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtypees_ES
dc.subject.meshInfluenza A viruses_ES
dc.subject.meshInfluenza B viruses_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshPandemicses_ES
dc.subject.meshPneumonia, Virales_ES
dc.subject.meshPopulation Surveillancees_ES
dc.subject.meshRNA, Virales_ES
dc.subject.meshSARS-CoV-2es_ES
dc.subject.meshSequence Analysis, DNAes_ES
dc.titleVirological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemices_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublicatione2df6e55-f1d3-423b-a72f-fd9a69cf5915
relation.isAuthorOfPublication.latestForDiscovery5611ffc3-de88-4908-b20a-9a15a58c060a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
VirologicalSurveillanceOfInfluenza_2020.pdf
Size:
479.48 KB
Format:
Adobe Portable Document Format
Description: